Core Outcome Measures in Effectiveness Trials

Development of a core outcomes set to standardise reporting in atypical endometrial hyperplasia

General Information

Summary:
Recognised methodology, which engages all key stakeholders (clinicians, patients and their associates, charities), will be used to develop the COS. Systematic reviews of the literature and workshops with stakeholders will be conducted to identify potential core outcomes. A Delphi survey will then be used to reach consensus regarding outcomes to be included in the core set, which will be subsequently refined through fact-to-face consensus discussions.

Contributors:
Dr Natalie A.M. Cooper, Queen Mary University of London
Dr Carol Rivas, University of Southampton
Dr Ranjit Manchanda, Queen Mary University of London
Dr Elly Brockbank, Barts Health NHS Trust
Professor P Sasieni, Queen Mary University of London
(PI) Professor Khalid Khan, Queen Mary University of London

Further Study Information

Current Stage:
Ongoing
Date:
April 2017 - April 2019
Funding source(s):
Cancer Research UK

Health Area

Disease Category
Gynaecology

Disease Name
Atypical Endometrial Hyperplasia

Target Population

Age Range
18 - 99

Sex
Female


Nature / type of Intervention
Any

Method(s)

Consensus meeting
Delphi process
Interview
Literature review
Semi structured discussion
Survey
Systematic review

A gynaecological diagnosis can have an effect on the patient’s partner, therefore we will ensure that their opinions are considered during development of the core outcome set by including them as participants in the workshops.

Methodology which engages all key stakeholders (clinicians, patients, researchers, charities) will be used to develop the core outcome set. Systematic reviews of the literature and patient workshops will be conducted to identify potential core outcomes. A Delphi survey of all relevant stakeholders will then be used to reach consensus regarding outcomes to be included in the core set, which will be subsequently refined through fact-to-face consensus discussions. The final core outcome sets will be disseminated via publication.


Stakeholders Involved

Charities
Clinical experts
Conference participants
Consumers (caregivers)
Consumers (patients)
Epidemiologists
Families
Journal editors
Patient/ support group representatives
Researchers
Service providers
Service users

Study Type

COS for clinical trials or clinical research

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.